RGD Reference Report - IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling.

Authors: Valverde, AM  Gonzalez-Rodriguez, A 
Citation: Valverde AM and Gonzalez-Rodriguez A, Arch Physiol Biochem. 2011 Jul;117(3):105-15. doi: 10.3109/13813455.2011.557386. Epub 2011 Mar 14.
RGD ID: 7248548
Pubmed: PMID:21401320   (View Abstract at PubMed)
DOI: DOI:10.3109/13813455.2011.557386   (Journal Full-text)

Type 2 Diabetes mellitus (T2D) is the most common endocrine disorder associated to metabolic syndrome (MS) and occurs when insulin secretion can no compensate peripheral insulin resistance. Among peripheral tissues, the liver controls glucose homeostasis due to its ability to consume and produce glucose. The molecular mechanism underlying hepatic insulin resistance is not completely understood; however, it involves the impairment of the insulin signalling network. Among the critical nodes of hepatic insulin signalling, insulin receptor substrate 2 (IRS2) and protein tyrosine phosphatase 1B (PTP1B) modulate the phosphatidylinositol (PI) 3-kinase/Akt/Foxo1 pathway that controls the suppression of gluconeogenic genes. In this review, we will focus on recent findings regarding the molecular mechanism by which IRS2 and PTP1B elicit opposite effects on carbohydrate metabolism in the liver in response to insulin. Finally, we will discuss the involvement of the critical nodes of insulin signalling in non-alcoholic fatty liver disease (NAFLD) in humans.


Additional Information